Moderna expands beyond vaccines while Recursion bets on AI-driven drug discovery, each with distinct risks, partnerships, and financial profiles.

As Toronto emerges as one of North America’s most active applied AI hubs, an Indian-origin engineering leader is among the practitioners building the quieter infrastructure — peer-reviewed research, ...

U.S. federal health leaders are advancing a coordinated strategy to embed AI into healthcare, emphasizing infrastructure, ...

The harder question now is supervisory: how can regulators see, interpret and supervise digital asset activity across users, ...

A research team has developed a machine learning–based quantitative structure–activity relationship (ML-QSAR) method to ...

AI drug discovery cleared its first Phase IIa clinical test in 2025, as BIO 2026 confirmed the shift from speculation to ...

QuantRate, a quantitative trading technology company specializing in AI-driven financial systems, today announced the launch ...

The global Automotive AI Chipset Market is entering a rapid growth phase as automakers, semiconductor companies, and mobility ...

JPMorgan’s midyear outlook argues the hyperscalers are profitable, the debt markets are holding, and the cycle has room to ...

America’s next major exascale supercomputer already has its first scientific challenges lined up. The Discovery supercomputer is not expected to go online until 2028, but the US Department of Energy ...

Solana Unchained enters its final hours of Phase 3 as the project prepares for a transition in its token allocation structure. The ecosystem, which focuses on integrating machine learning tools with ...

Microsoft CEO Satya Nadella cautions against an AI economy dominated by a few models, warning of industry commoditisation and the loss of unique expertise.